Aug.14, 2009 Health and Fitness Tags : ADD, Adderall, ADHD, Advisory Panel, Arrhythmia, Attention Deficit Disorder, Chest Pain, Committee Member, concerta, Drug Medication, Drug Reactions, Federal Drug Administration, Heart Attacks, Heart Problems, high blood pressure, irregular heart beats, Risk Of Heart Disease, Ritalin, Stimulant Drug, Stimulants, Symptoms Of Attention Deficit Disorder, Unexplained Deaths Related Posts:ADHD – Are there Treatment Options?Recognizing the Risks and Side Effec

Jul.31, 2009 Health and Fitness Tags : ADD, Add Coach, Adderall, ADHD, adhd coach, Antidepressants, attention, Attention Deficit Disorder, Behavior Modification Techniques, Communication Goal, concerta, deficit, Dennis The Menace, Dexedrine, disorder, Hyperactivity, Interest Inventories, Layperson, Maximum Effectiveness, Mental Health Practitioner, Paxil, Psychiatrist, Ritalin, Social Worker, Stimulants, Treatment Options, Wellbutrin Related Posts:What is ADHD?Natural ADD Supplements — Say No

The list of medications for ADHD/attention deficit disorder with hyperactivity is a long one with new options being added on a regular basis. Fifteen years ago the list of medications for ADHD was a short one, with Ritalin being the shining star. Ritalin is what is known in the medical community as a short term stimulant prescription medication for ADHD. Some suggest that Ritalin was rushed to the market. They point to the fact that it was not unanimously approved for safety by the FDA, but none

Der Washington Post zufolge werfen aktuelle Erkenntnisse ein zweifelhaftes Licht auf Medikamente wie Ritalin, mit denen weit überwiegend Jungen ruhiggestellt werden, bei denen ADHS (das sogenannte "Zappelphilipp-Syndrom" ) diagnostiziert wurde: New data from a large federal study have reignited a debate over the effectiveness of long-term drug treatment of children with hyperactivity or attention-deficit disorder, and have drawn accusations that some members of the research team have sought t

March 27, 2009 New data from a large federal study have reignited a debate over the effectiveness of long-term drug treatment of children with hyperactivity or attention-deficit disorder, and have drawn accusations that some members of the research team have sought to play down evidence that medications do little good beyond 24 months.